prostatepedia magazine covers

 

Prostatepedia features informal conversations with doctors, patients, and activists about prostate cancer about prostate cancer. Each month they tackle a different topic facing prostate cancer patients today—from how imaging has impacted treatment to dealing with erectile dysfunction after radiation or surgery to the evolving field of immunotherapy.

Prostatepedia Magazine (quarterly) and the weekly Prostatepedia Digests became part of NASPCC starting with the August 2020 issue.

Use this link to learn more about Prostatepedia...

Current and Future Trends

Recorded: June 24, 2021

Program Description

Topics will cover the landscape of immunotherapy options in prostate cancer; novel mechanisms of action; BiTE antibodies; Car-T Cell Therapy; the use of pembrolizumab in advanced prostate cancer, and future perspectives.

Faculty presenters:

  • Saul Priceman, PhD City of Hope Medical Center - Presenter and Moderator
  • Rahul Aggarwal, MD University of California,
  • Charles Drake, MD, PhD New York-Presbyterian/Columbia
  • Lawrence Fong, MD University of California, San Francisco
  • James Gulley, MD, PhD National Institutes of Health
  • John Lee, MD, PhD Fred Hutchinson Cancer Center, Seattle
  • Vivek Narayen, MD, MS University of Pennsylvania
  • Sumit Subudhi, MD, PhD M.D. Anderson Cancer, Houston

Video presentations

  1. Introduction - Video
    Merel Nissenberg, Esq., President, NASPCC

  2. Introductory Remarks - Video
    Saul Priceman, PhD

  3. Redirecting T-Cells for Prostate Cancer Immunotherapy - Video
    Lawrence Fong, MD

  4. CAR-T Development in Sub-Types of Prostate Cancer: How Mechanistic Biology Impacts Future Therapies - Video
    John Lee, MD, PhD
  5. Chimeric Antigen Receptor T-Cell Therapies for Advanced Prostate Cancer: Clinical Trials (and Tribulations) - Video
    Vivek Narayen, MD, MS

  6. Advancing CAR-T Cells for Prostate Cancer - Video
    Saul Priceman, PhD

  7. Panel Discussion

  8. Upcoming Clinical Trial of DLL3/CF3 BiTE in Neuroendocrine Prostate Cancer - Video
    Rahul Aggarwal, MD

  9. Anti-CTLA-4-Therapy in Prostate Cancer - Video
    Sumit Subudhi, MD, PhD

  10. The QuEST for an Effective Immunotherapy for Prostate Cancer - Video
    James Gulley, MD, PhD

  11. Allogenic Approaches to Cell Therapy for Tumors of Various Sorts - Video
    Charles Drake, MD, PhD

  12. Panel Discussion

  13. Closing Remarks

Handouts in PDF Format

  1. Introductory Remarks - PDF
    Saul Priceman, PhD

  2. Redirecting T-Cells for Prostate Cancer Immunotherapy - PDF
    Lawrence Fong, MD

  3. CAR-T Development in Sub-Types of Prostate Cancer: How Mechanistic Biology Impacts Future Therapies - PDF
    John Lee, MD, PhD

  4. Chimeric Antigen Receptor T-Cell Therapies for Advanced Prostate Cancer: Clinical Trials (and Tribulations) - PDF
    Vivek Narayen, MD, MS

  5. Advancing CAR-T Cells for Prostate Cancer - PDF
    Saul Priceman, PhD

  6. Upcoming Clinical Trial of DLL3/CF3 BiTE in Neuroendocrine Prostate Cancer - PDF
    Rahul Aggarwal, MD

  7. Anti-CTLA-4-Therapy in Prostate Cancer - PDF
    Sumit Subudhi, MD, PhD

  8. The QuEST for an Effective Immunotherapy for Prostate Cancer - PDF
    James Gulley, MD, PhD

  9. Allogenic Approaches to Cell Therapy for Tumors of Various Sorts - PDF
    Charles Drake, MD, PhD

Other Resources

 

Sponsored by AMGEN

 

rev: 08/07/2021

Attachments:
Download this file (I-O-Symposium-Agenda-Fin.pdf)Symposium Agenda Fin PDF[ ]102 kB